EU Approval Recommendations: Strong Showing From Orphans & Biosimilars

The CHMP has recommended 11 products for approval at its latest meeting, including four orphan medicines, three biosimilars and two generics. It also recommended harmonizing the product labeling for two etoposide products.

Thumbs up
The CHMP OKd 11 products in April, including orphans and biosimilars

More from Approvals

More from Product Reviews